Results 1 to 10 of about 6,941 (175)
Molecular Landscape of Vulvar Squamous Cell Carcinoma [PDF]
International Journal of Molecular Sciences, 2021 Vulvar squamous cell carcinoma (VSCC) is a rare malignancy with dual pathogenesis, Human papillomavirus (HPV)-associated and HPV-independent, with a poorly explored molecular landscape. We aimed to summarize the findings of the series analyzing molecular hallmarks of this neoplasm.
Natalia Rakislova +2 more
exaly +5 more sources
Vulvar sarcomatoid squamous cell carcinoma: A rare entity
Indian Dermatology Online Journal, 2023 Vulvar squamous cell carcinoma with sarcomatoid features is an extremely rare histological variant of squamous cell carcinoma with co-existence of both epithelial and mesenchymal features.
Gayatri Gund +3 more
doaj +3 more sources
Case report: A kidney metastasis from vulvar squamous cell carcinoma [PDF]
Frontiers in Oncology, 2023 IntroductionDistant metastases of vulvar SCC most commonly involve the lung, liver, bone, skin, and lymph nodes. Metastasis from vulvar SCC to the kidneys is extremely rare, with only one case reported in the literature to date.Case presentationWe report
Junwei He +11 more
doaj +2 more sources
HPV-independent vulvar squamous cell carcinoma: a case report and review of the literature [PDF]
Einstein (São Paulo)Vulvar cancer, a rare gynecological malignancy, accounts for 3-5% of cases and is most commonly squamous cell carcinoma. Prognosis is poorer in cancers unrelated to human papillomavirus (HPV), often associated with chronic inflammation.
Raphael Federicci Haddad +6 more
doaj +2 more sources
Current Preoperative Management of Vulvar Squamous Cell Carcinoma: An Overview [PDF]
CancersVulvar carcinoma is a rare cancer affecting the genital tract, constituting 4% of gynecological tumors. Vulvar squamous cell carcinoma (VSCC) is the most common type. Diagnosis relies on biopsy during vulvoscopy, plus imaging such as ultrasonography (USG), magnetic resonance imaging (MRI) and positron emission tomography (PET).
Simona Zaami +2 more
exaly +5 more sources
Rare phalanges soft tissue and bony metastasis in vulvar squamous cell carcinoma: Case report [PDF]
Gynecologic Oncology ReportsVulvar cancer accounts for 0.3 % of new cancer cases within the Unites States. Metastatic vulvar cancer with disease beyond the pelvis is rare and has a poor prognosis. Data on primary treatment including systemic treatments for distant metastatic vulvar
Landon Foulger +3 more
doaj +2 more sources
Viruses, 2023 Approximately 40% of vulvar squamous cell carcinoma (vSCC) cases are etiologically associated with high-risk human papillomaviruses (HPVs) of the alpha genera (α-HPV) that cause other anogenital cancers; however, the etiology of α-HPV-negative vSCC is ...
Taja Lozar +10 more
doaj +1 more source
Gynecologic Oncology Reports, 2022 There are limited treatment options for patients with advanced vulvar cancer. However, several immune checkpoint inhibitors (ICIs) are FDA-approved or NCCN-Compendia–listed for qualified patients with advanced disease.
Aaron Praiss +5 more
doaj +1 more source
Gynecologic Oncology Reports, 2023 Patients with human immunodeficiency virus (HIV) are at increased risk for developing other gynecologic conditions, including herpes simplex virus (HSV) and vulvar intraepithelial neoplasia (VIN)/carcinoma.
Rachel McKean +4 more
doaj +1 more source
Journal of Ultrasonography, 2019 Vulvar cancer is a malignancy of female lower genital tract with incidence of 1:100,000 in Poland. The most common types of vulvar cancers are squamous cell carcinoma and basal cell carcinoma.
Michał Migda +3 more
doaj +1 more source